Chapter 15: Potential Therapies
In this Chapter…
- New Drugs
- Trophic Factors
- Engineered Antibodies
- Small Molecules and RNAs
- Cell and Gene Therapy
New Drugs
- Most medications today are developed using trial-and-error
- The potency of the agent can be determined by how well it attaches to the receptor/protein target in a test tube
- Candidates for new neurological drugs include * trophic factors * antibodies engineered to modify the interactions and toxicity of misfolded proteins * interfering RNAs * They could reduce the toxic levels of individual proteins * Stem cells * They could replace dead or dying neurons
Trophic Factors
- Trophic factors control the development and survival of specific groups of neurons
- Once specific actions of these molecules and their receptors are identified, their genes can be cloned * Procedures can be developed to modify trophic factor-regulated functions in ways that might be useful in the treatment of neurological disorders
- : a trophic factor that slows the destruction of neurons that use acetylcholine * A possible treatment * Prevented cell death & stimulated regeneration & sprouting of damaged neurons that are known to die in Alzheimer’s disease * Holds promise for slowing memory deficits associated with aging
- Neutralizing molecules that stop or inhibit growth can help repair damaged nerve fiber tracts in the spinal cord * Antibodies that override the effect of Nogo-A helped some nerves of damaged spinal cords to regrow * : a protein that inhibits nerve regeneration
Engineered Antibodies
- We can “trick” the immune system into attacking proteins that cause neurological disease by vaccinating against them * There’s a risk of increased inflammation when the brain reacts to antibodies against its proteins
- A new approach is to engineer fragments of antibodies that can bind to and alter disease characteristics of specific proteins * These have produced promising results for Huntington’s, Parkinson’s, Alzheimer’s, and prion diseases
- Fruit flies that have been modified to carry a mutant gene for Huntington’s are generally too weak & uncoordinated to break out of their pupal case * When treated to also express a gene for anti-HD antibodies, all emerge as young adults * Treated flies live longer than untreated ones that manage to emerge and show less pathology in their brains
Small Molecules and RNAs
- Small-molecule drug candidates can be tested using high-throughput screening
- Many neurological diseases involve denatured proteins
- Lasers are used to measure whether proteins are clumped inside cells that have been distributed into containers with small molecules * They scan containers and report whether particular drugs have changed protein clumping
- Many diseases also involve the accumulation of abnormal proteins * If cells made fewer such proteins, the disease would slow down
- A new class of drugs involves removing the RNAs that code for these proteins
Cell and Gene Therapy
- - unspecialized cells that give rise to cells with specific functions
- Neuronal stem cells can continuously produce all 3 cell types present in the brain: * Neurons * - glial cells that protect and nourish neurons * - glial cells that surround axons and make the myelin sheath
- Viruses may be able to carry therapeutic genes into the brain to correct central nervous system diseases
\ \